Evidence map›Paper›PMID 27031105›Full record

ArticlePloS one2016

Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?

Saverio Caini, Winston Andrade, Selim Badur, Angel Balmaseda, Amal Barakat, Antonino Bella, Abderrahman Bimohuen, Lynnette Brammer, Joseph Bresee, Alfredo Bruno and 51 more

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Corticosteroids as adjunctive therapy in the treatment of influenza.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Trial
  3. Global influenza epidemiology after 2020: patterns of circulation, epidemic timing and duration, and implications for vaccination strategies.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Concepts and methods for predicting viral evolution.bioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

61 authors.

Saverio CainiNetherlands Institute for Health Services Research (NIVEL), Utrecht, The Netherlands.
Winston AndradeSección de Virus Respiratorios y Exantemáticos, Instituto de Salud Pública de Chile, Santiago de Chile, Chile.
Selim BadurIstanbul University, Istanbul, Turkey.
Angel BalmasedaNational Influenza Center, Ministry of Health, Managua, Nicaragua.
Amal BarakatNational Influenza Center, Institut National d'Hygiène, Ministry of Health, Rabat, Morocco.
Antonino BellaNational Center for Epidemiology, Surveillance and Health Promotion National Institute of Health, Rome, Italy.
Abderrahman BimohuenNational Influenza Center, Institut National d'Hygiène, Ministry of Health, Rabat, Morocco.
Lynnette BrammerEpidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Joseph BreseeEpidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Alfredo BrunoCentro de Referencia Nacional de Influenza y Otros Virus Respiratorios, Instituto Nacional de Investigación en Salud Pública (INSPI), Guayaquil, Ecuador.
Leticia CastilloNational Influenza Center, Ministry of Health, Guatemala City, Guatemala.
Meral A CiblakIstanbul University, Istanbul, Turkey.
Alexey W ClaraUS Centers for Disease Control, Central American Region, Guatemala City, Guatemala.
Cheryl CohenCentre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases, Johannesburg, South Africa.
Jeffery CutterCommunicable Diseases Division, Ministry of Health, Singapore, Singapore.
Coulibaly DaoudaRespiratory Viruses Unit, Pasteur Institute of Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Celina de LozanoNational Influenza Center, Ministry of Health, San Salvador, El Salvador.
Domenica De MoraCentro de Referencia Nacional de Influenza y Otros Virus Respiratorios, Instituto Nacional de Investigación en Salud Pública (INSPI), Guayaquil, Ecuador.
Kunzang DorjiPublic Health Laboratory, Department of Public Health, Ministry of Health, Thimphu, Bhutan.
Gideon O EmukuleUS Centers for Disease Control and Prevention, Nairobi, Kenya.
Rodrigo A FasceSección de Virus Respiratorios y Exantemáticos, Instituto de Salud Pública de Chile, Santiago de Chile, Chile.
Luzhao FengDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Walquiria Aparecida Ferreira de AlmeidaMinistry of Health, Brasília, DF, Brazil.
Raquel GuiomarNational Influenza Reference Laboratory, Infectious Diseases Department, National Institute of Health, Lisbon, Portugal.
Jean-Michel HeraudNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar.
Olha HolubkaL.V.Gromashevsky Institute of Epidemiology and Infectious Diseases National Academy of Medical Science of Ukraine, Kiev, Ukraine.
Q Sue HuangInstitute of Environmental Science and Research, Wellington, New Zealand.
Herve A KadjoRespiratory Viruses Unit, Pasteur Institute of Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Lyazzat KiyanbekovaZonal Virology Laboratory, Astana Center of Sanitary Epidemiology Expertise, Astana, Kazakhstan.
Herman KosasihUS Naval Medical Research Unit No. 2, Jakarta, Indonesia.
Gabriela KusznierzInstituto Nacional de Enfermedades Respiratorias "Dr. Emilio Coni," Santa Fe, Argentina.
Jenny LaraNational Influenza Center, Ministry of Health, San José, Costa Rica.
Ming LiDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Liza LopezInstitute of Environmental Science and Research, Wellington, New Zealand.
Phuong Vu Mai HoangNational Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Cláudio Maierovitch Pessanha HenriquesMinistry of Health, Brasília, DF, Brazil.
Maria Luisa MatuteNational Influenza Center, Ministry of Health, Tegucigalpa, Honduras.
Alla MironenkoL.V.Gromashevsky Institute of Epidemiology and Infectious Diseases National Academy of Medical Science of Ukraine, Kiev, Ukraine.
Brechla MorenoNational Influenza Center, IC Gorgas, Panama City, Panama.
Joshua A MottUS Centers for Disease Control and Prevention, Nairobi, Kenya.
Richard NjouomService de Virologie, Centre Pasteur du Cameroun, Yaounde, Cameroon.
NurhayatiUS Naval Medical Research Unit No. 2, Jakarta, Indonesia.
Akerke OspanovaZonal Virology Laboratory, Astana Center of Sanitary Epidemiology Expertise, Astana, Kazakhstan.
Rhonda OwenVaccine Preventable Diseases Surveillance Section, Health Policy Protection Branch, Office of Health Protection, Department of Health, Woden, Australia.
Richard PebodyRespiratory Diseases Department, Public Health England, Colindale, United Kingdom.
Kate PenningtonVaccine Preventable Diseases Surveillance Section, Health Policy Protection Branch, Office of Health Protection, Department of Health, Woden, Australia.
Simona PuzelliNational Influenza Center, National Institute of Health, Rome, Italy.
Mai Thi Quynh LeNational Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Norosoa Harline RazanajatovoNational Influenza Center, Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar.
Ana RodriguesNational Institute of Health, Epidemiology Department, Lisbon, Portugal.
Juan Manuel RudiInstituto Nacional de Enfermedades Respiratorias "Dr. Emilio Coni," Santa Fe, Argentina.
Raymond Tzer Pin LinCommunicable Diseases Division, Ministry of Health, Singapore, Singapore.
Marietjie VenterGlobal Disease Detection, US-CDC, Pretoria, South Africa.
Marie-Astrid VernetService de Virologie, Centre Pasteur du Cameroun, Yaounde, Cameroon.
Sonam WangchukPublic Health Laboratory, Department of Public Health, Ministry of Health, Thimphu, Bhutan.
Juan YangDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Hongjie YuDivision of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China.
Maria ZambonRespiratory Virus Unit, Public Health England, Colindale, United Kingdom.
François SchellevisNetherlands Institute for Health Services Research (NIVEL), Utrecht, The Netherlands.
John PagetNetherlands Institute for Health Services Research (NIVEL), Utrecht, The Netherlands.
Global Influenza B Study

Funding

Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09U01IP001048 · IP · NATIONAL HEALTH LABORATORY SERVICE · PI COHEN, CHERYL · 2016 to 2020
$19.9M
NCIRD CDC HHS U01 IP001048
6 · The paper itself

Abstract

introductionDetermining the optimal time to vaccinate is important for influenza vaccination programmes. Here, we assessed the temporal characteristics of influenza epidemics in the Northern and Southern hemispheres and in the tropics, and discuss their implications for vaccination programmes.

methodsThis was a retrospective analysis of surveillance data between 2000 and 2014 from the Global Influenza B Study database. The seasonal peak of influenza was defined as the week with the most reported cases (overall, A, and B) in the season. The duration of seasonal activity was assessed using the maximum proportion of influenza cases during three consecutive months and the minimum number of months with ≥80% of cases in the season. We also assessed whether co-circulation of A and B virus types affected the duration of influenza epidemics.

results212 influenza seasons and 571,907 cases were included from 30 countries. In tropical countries, the seasonal influenza activity lasted longer and the peaks of influenza A and B coincided less frequently than in temperate countries. Temporal characteristics of influenza epidemics were heterogeneous in the tropics, with distinct seasonal epidemics observed only in some countries. Seasons with co-circulation of influenza A and B were longer than influenza A seasons, especially in the tropics. DISCUSSION: Our findings show that influenza seasonality is less well defined in the tropics than in temperate regions. This has important implications for vaccination programmes in these countries. High-quality influenza surveillance systems are needed in the tropics to enable decisions about when to vaccinate.

Indexed as

VaccinationHumansInfluenza A virusInfluenza B virusInfluenza, HumanRetrospective StudiesSeasonsTropical Climate

Identifiers

PMID27031105
PMCPMC4816507

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.